S-adenosyl-L-methionine prevents disruption of canalicular function and pericanalicular cytoskeleton integrity caused by cyclosporin A in isolated rat hepatocyte couplets.
Isolated rat hepatocyte couplets were used to study the effect of S-adenosyl-L methionine (SAMe) treatment on disruption of canalicular function caused by cyclosporin A (CyA). Canalicular function was assessed by counting the percentage of couplets that were able to accumulate the fluorescent cholephile choly-lysyl-fluorescein (CLF) into the canalicular vacuole between the two cells, i.e., canalicular vacuole accumulation (CVA). Cotreatment with 1 mmol/L SAMe prevented the inhibition of canalicular vacuole accumulation caused by CyA (75 nmol/L and 100 nmol/L), whereas treatment with it after CyA was unsuccessful. SAMe prevented the dose dependent reduction caused by CyA (5 nmol/L-1 mumol/L) both on CVA and on retention of CLF preaccumulated within the canaliculus, the effect on retention being complete. No difference in intracellular content of reduced glutathione (GSH) between the control and any dose level of the immunosuppressor, with or without SAMe treatment was observed, suggesting that changes in intracellular reduced GSH levels are not involved in the effects of SAMe. F-actin was stained with fluorescein-isothiocyanate phalloidin and fluorescence measurements were performed by confocal microscopy. The ratio of the percanalicular area fluorescence/total couplet fluorescence, indicative of F-actin distribution, significantly decreased with CyA. However, cotreatment of CyA with SAMe protected the integrity of the pericanalicular cytoskeleton, suggesting that this beneficial effect on canalicular function may maintain canalicular contractions and/or preserve tight junction function. Results are discussed in relation to possible involvement of the transmethylation pathway, modifications in membrane fluidity, effects on bile acid transport, and of inhibition of uptake of CyA. They suggest that SAMe could be a good candidate for protecting against CyA-induced membrane dysfunction.
Román
I D
ID
School of Biochemistry, The University of Birmingham, Edgbaston, England.
Johnson
G D
GD
Coleman
R
R
D000199:Actins / Q000032:analysis; D000818:Animals; D001648:Bile Canaliculi / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D002478:Cells, Cultured; D002793:Cholic Acids; D016572:Cyclosporine / Q000633:toxicity*; D003599:Cytoskeleton / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D005452:Fluoresceins; D005456:Fluorescent Dyes; D005978:Glutathione / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000633:toxicity*; D008099:Liver / Q000187:drug effects / Q000473:pathology* / Q000648:ultrastructure; D008297:Male; D010590:Phalloidine / Q000031:analogs & derivatives; D051381:Rats; D017208:Rats, Wistar; D012436:S-Adenosylmethionine / Q000494:pharmacology*; D014617:Vacuoles / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure
D000199:Actins; D002793:Cholic Acids; D005452:Fluoresceins; D005456:Fluorescent Dyes; D007166:Immunosuppressive Agents; C072313:cholyl-lysylfluorescein; C037191:fluorescein isothiocyanate-phalloidin; D010590:Phalloidine; D012436:S-Adenosylmethionine; D016572:Cyclosporine; D005978:Glutathione